Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
14.01
-0.17 (-1.20%)
At close: Jun 26, 2026, 4:00 PM EDT
14.18
+0.17 (1.21%)
After-hours: Jun 26, 2026, 7:45 PM EDT
Summit Therapeutics Employees
Summit Therapeutics had 265 employees as of December 31, 2025. The number of employees increased by 106 or 66.67% compared to the previous year.
Employees
265
Change (1Y)
106
Growth (1Y)
66.67%
Revenue / Employee
n/a
Profits / Employee
-$4,551,309
Market Cap
10.87B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 265 | 106 | 66.67% |
| Dec 31, 2024 | 159 | 54 | 51.43% |
| Dec 31, 2023 | 105 | 28 | 36.36% |
| Dec 31, 2022 | 77 | -33 | -30.00% |
| Dec 31, 2021 | 110 | 29 | 35.80% |
| Dec 31, 2020 | 81 | 11 | 15.71% |
| Dec 31, 2019 | 70 | 9 | 14.75% |
| Dec 31, 2018 | 61 | -15 | -19.74% |
| Dec 31, 2017 | 76 | 36 | 90.00% |
| Dec 31, 2016 | 40 | 3 | 8.11% |
| Dec 31, 2015 | 37 | 14 | 60.87% |
| Dec 31, 2014 | 23 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Ionis Pharmaceuticals | 1,402 |
| Axsome Therapeutics | 1,220 |
| Exelixis | 1,077 |
| Madrigal Pharmaceuticals | 915 |
| Arrowhead Pharmaceuticals | 711 |
| Cytokinetics | 673 |
SMMT News
- 16 days ago - Summit Therapeutics withdraws proposed underwritten public offering - TheFly
- 17 days ago - Summit Therapeutics falls -10.2% - TheFly
- 17 days ago - Summit Therapeutics put volume heavy and directionally bearish - TheFly
- 17 days ago - Summit Therapeutics Transcript: AGM 2026 - Transcripts
- 18 days ago - Summit Therapeutics announces $500M common stock offering - TheFly
- 18 days ago - Summit Therapeutics Announces Proposed Public Offering of Common Stock - Business Wire
- 18 days ago - Summit Therapeutics files automatic mixed securities shelf - TheFly
- 19 days ago - Summit Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts